- Title: Subtitle
- QCT Imaging-Based Clusters of Former Smokers Identify Clinical Phenotypes in the SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS)
- Creators
- S. Choi - Kyungpook National UniversityBabak HaghighiEric A Hoffman - University of Iowa, RadiologyJohn D Newell Jr - University of Iowa, RadiologyAlejandro P Comellas Freymond - University of Iowa, Pulmonary, Critical Care, and Occupational MedicineRobert Graham Barr - Columbia University Irving Medical CenterMeiLan K. Han - University of MichiganC.B. Cooper - University of California, Los AngelesW.K. O’Neal - University of North Carolina at Chapel HillPrescott Woodruff - University of California, San FranciscoF.J. Martinez - Cornell UniversityE.R. Bleecker - University of ArizonaRussell P Bowler - National Jewish HealthJ.A. Krishnan - University of Illinois ChicagoR E Kanner - University of UtahRobert Paine III - University of UtahS.P. Peters - Wake Forest UniversityMark T Dransfield - University of Alabama at BirminghamN.N. Hansel - Johns Hopkins UniversityChing-Long Lin - University of Iowa, Mechanical EngineeringGerard Criner - Temple University HospitalDavid Couper - University of North Carolina at Chapel HillS.P. Bhatt - University of Alabama at Birmingham
- Resource Type
- Abstract
- Publication Details
- American journal of respiratory and critical care medicine, Vol.917, A6387
- Conference
- Annual American Thoracic Society Meeting (San Diego, California, 05/18/2018–05/23/2018)
- ISSN
- 1073-449X
- eISSN
- 1535-4970
- Publisher
- American Thoracic Society
- Grant note
- NIH Grants U01-HL114494, R01-HL112986 and S10-RR022421.SPIROMICS was supported by contracts from the NIH/NHLBI (HHSN268200900013C,HHSN268200900014C, HHSN268200900015C, HHSN268200900016C,HHSN268200900017C, HHSN268200900018C, HHSN268200900019C,HHSN268200900020C), and supplemented by contributions made through the Foundation forthe NIH and the COPD Foundation from AstraZeneca/MedImmune; Bayer; BellerophonTherapeutics; Boehringer-Ingelheim Pharmaceuticals, Inc..; Chiesi Farmaceutici S.p.A.; ForestResearch Institute, Inc.; GlaxoSmithKline; Grifols Therapeutics, Inc.; Ikaria, Inc.; Nycomed GmbH;Takeda Pharmaceutical Company; Novartis Pharmaceuticals Corporation; ProterixBio;Regeneron Pharmaceuticals, Inc.; Sanofi; and Sunovion. This study is also supported by BasicScience Research Program through the National Research Foundation of Korea (NRF) fundedby the Ministry of Education (NRF-2017R1D1A1B03034157)
- Language
- English
- Date published
- 05/2018
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Radiology; Pulmonary, Critical Care, and Occupational Medicine; ICTS; Mechanical Engineering; Internal Medicine
- Record Identifier
- 9984564940602771
Abstract
QCT Imaging-Based Clusters of Former Smokers Identify Clinical Phenotypes in the SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS)
American journal of respiratory and critical care medicine, Vol.917, A6387
Annual American Thoracic Society Meeting (San Diego, California, 05/18/2018–05/23/2018)
05/2018
Details
Metrics
13 Record Views